Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17194902

Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Jan 1
First author
Ribera JM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Jun 20;25(18):2625-6; author reply 2627-8. doi: 10.1200/JCO.2007.11.5014.
    note
    Source null
    related pmid
    17577046
    relationship
    Comment in

Authors and identifiers

  1. name
    Ribera JM
    type
    Author
  2. name
    Ortega JJ
    type
    Author
  3. name
    Oriol A
    type
    Author
  4. name
    Bastida P
    type
    Author
  5. name
    Calvo C
    type
    Author
  6. name
    Pérez-Hurtado JM
    type
    Author
  7. name
    González-Valentín ME
    type
    Author
  8. name
    Martín-Reina V
    type
    Author
  9. name
    Molinés A
    type
    Author
  10. name
    Ortega-Rivas F
    type
    Author
  11. name
    Moreno MJ
    type
    Author
  12. name
    Rivas C
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Ribera JM
    type
    Author
  2. name
    Ortega JJ
    type
    Author
  3. name
    Oriol A
    type
    Author
  4. name
    Bastida P
    type
    Author
  5. name
    Calvo C
    type
    Author
  6. name
    Pérez-Hurtado JM
    type
    Author
  7. name
    González-Valentín ME
    type
    Author
  8. name
    Martín-Reina V
    type
    Author
  9. name
    Molinés A
    type
    Author
  10. name
    Ortega-Rivas F
    type
    Author
  11. name
    Moreno MJ
    type
    Author
  12. name
    Rivas C
    type
    Author
bibliography ids
  1. nci-bib-bfbb94e28d42a56e42960e67
book metadata
content sha256
e8cfa5236a74bd8ff1d37a9c4ae1e7853419d5b6727faec57adccb59813dd14e
document type
citation
dois
  1. 10.1200/JCO.2006.06.8312
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:17194902
immutable id
pubmed:17194902@e8cfa5236a74bd8ff1d37a9c4ae1e7853419d5b6727faec57adccb59813dd14e
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
16-24
volume
25
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2007 Jun 20;25(18):2625-6; author reply 2627-8. doi: 10.1200/JCO.2007.11.5014.
    note
    Source null
    related pmid
    17577046
    relationship
    Comment in
outcomes validated
false
pmid
17194902
provenance
batch id
e687ecc838c318f9ec65
provider
NCBI PubMed ESummary
record sha256
301ab3669ac0aa09fb8544395f6912c75b40ffcc2d6f9919748670be22fa711a
response sha256
57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
retrieved at
2026-09-09T23:46:11.674833+00:00
publication date
display
2007 Jan 1
precision
day
year
2007
publication types
  1. Clinical Trial
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17194902/
title
Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.

Preserved source evidence · Not medical advice